Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Multiconsult Norge AS contract award with Vestland Fylkeskommune | Bybanen utbygging for D73 Bicycle path Fløen - Kronstad in Bergen

Vestland Fylkeskommune | Bybanen utbygging has selected Multiconsult Norge AS with Amberg Norge AS as subcontractor, to provide detailed planning and design of “D73 Prosjektering sykkel Fløen - Kronstad” in Bergen, Norway. The contract value for Multiconsult will be in excess of NOK 29 million.Work will begin immediately, and detailed planning and design phase is planned to be completed in 2020. Vestland Fylkeskommune | Bybanen utbygging will build a pedestrian and bike path in the old railway tunnel. Part of the task will be to plan an extension part with tunnel in soils. Furthermore, a

Viking Line: Annual Financial Report

Viking Line Abp                           ANNUAL FINANCIAL REPORT             06.03.2020 3:10 PM The Annual Report of Viking Line Abp for the financial year 2019 has now been published on the Company's website at www.vikingline.com/en/investors/financial-reports/. A link to the report is also found below in this message. Copies of the 2019 financial statements will be available for viewing at the head office of the Company starting on March 10, 2020. The printed Annual Report in Swedish or Finnish will not be automatically sent by post to the Company's shareholders but can instead be

FundedByMe’s rights issue 100 percent guaranteed*

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, SOUTH KOREA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE ILLEGAL. FundedByMe announces that the issue communicated on March 4 is guaranteed by a consortium of guarantors, including several of the major owners, as well as existing co-owners. The issue guarantees make the rights issue 100 percent guaranteed.Summary of the issue · Summary of the issue · Shareholders in FundedByMe have the right to subscribe for two (2) Class A shares per

EIA process concerning the Kemi bioproduct mill concluded

Metsä Fibre press release 6.3.2020The Lapland ELY Centre (Centre for Economic Development, Transport and the Environment) issued its reasoned conclusion on the EIA report concerning the Kemi bioproduct mill of Metsä Fibre on 6 March 2020, thereby concluding the Environmental Impact Assessment (EIA). The ELY Centre, serving as the responsible authority, deems the report to be adequate in terms of its quality and to meet the content requirements pursuant to the Environmental Impact Assessment Act. The reasoned conclusion includes a description of the project and its environmental impact. The

Shawbrook Bank's Brentwood office kicks off celebrations to mark International Women's Day

To celebrate International Women's Day, Shawbrook Bank's offices across the UK are taking part in a range of celebratory activities. To kick things off, our Brentwood office in Essex have created a pledge board with colleagues committing to an action that will help forge a more gender equal world. Staff were also involved in donating funds to The Girls' Network, which aims to inspire and empower girls from least advantaged communities across the United Kingdom.  See our pictures attached...

ExpreS2ion announces EU grant award for the COVID-19 vaccine development programme

Hørsholm, Denmark, March 6, 2020 – Today, ExpreS[2]ion Biotechnologies ApS (“ExpreS[2]ion”), a fully owned subsidiary of ExpreS[2]ion Biotech Holding AB, announces that the consortium has been awarded an EU Horizon 2020 grant for the COVID-19 (SARS-CoV-2) Coronavirus vaccine development programme. The award funding amounts to 2,7 MEUR (28MSEK), of which ExpreS[2]ion directly is funded with 0.88 MEUR (9.3 MSEK).The aim of the grant is to support the consortium in development of a COVID-19 vaccine candidate, including performing a Phase I/IIa clinical trial. The ambitious aim is to initiate

TargetEveryone AB changes name to SpectrumOne AB

As previously announced on November 19, 2019, it was decided at an extraordinary shareholders’ meeting to change the name to SpectrumOne AB. The name change to SpectrumOne AB has now been registered with Swedish Companies Registration Office. The Company will trade under the new name SpectrumOne AB and with new ticker “SPONE-ME” on Merkur Market and ”SPEONE” on Nasdaq First North Growth Market from March 9, 2020. The ISIN will not change as a result of the name change. For further information contact: Hosni Teque-OmeiratCEO+46 70 225 18 77 hosni@spectrumone.com Certified

Bellman Group acquires SÅCAB

Bellman Group AB has today completed the acquisition of SÅCAB Åkericentral AB (SÅCAB). SÅCAB relays vehicles and machinery for all types of shafting and transport services within the construction industry and operates a recycling facility south of Stockholm. Through the acquisition, Bellman Group expands its capacity in the Stockholm region as well as gains access to its own recycling facility which is of strategic importance.Bellman Group acquires all shares in SÅCAB Åkericentral AB and indirectly its subsidiaries. The purchase price amounts to SEK 77 million paid in cash. SÅCAB

Important European patent approval for Episurf Medical within 3D visualisation

The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Method of generating a three dimensional representation of a joint”, covers a medical image segmentation process for 3D visualisation of anatomical joints. Image segmentation is a part of the technology around Episurf Medical’s individualised joint implants and surgical instruments. "This is a comprehensive patent for protection in the field of 3D visualisation of joints. The image-based segmentation forms the basis for all Episurf

Beijer Electronics Group AB issues class C shares

The Board of Beijer Electronics Group AB has decided to issue class C shares and to exercise its repurchase authorisation to secure Beijer Electronics Group’s obligations under the LTI 2019/2022 incentive programme.The 2019 Annual General Meeting of Beijer Electronics Group AB decided, with the aim of ensuring that the company can fulfil its obligations under the long-term incentive programme LTI 2019/2022 as voted for by the Annual General Meeting, to authorise the Board of Directors to decide on a directed issue of redeemable and convertible class C shares. Furthermore, the 2019 Annual

Notice to Solteq Plc’s Annual General Meeting 2020

Solteq Plc, Stock Exchange Bulletin, 6.3.2020 at 2 pm. Shareholders of Solteq Plc are hereby invited to the Annual General Meeting of Shareholders held on Wednesday 1 April, 2020 at 10 a.m. at Vantaa office of Solteq Plc, address Karhumäenkuja 2, 01530 Vantaa (Aviapolis II). The reception of the shareholders registered for the meeting begins at 9.30 a.m. A. Agenda of the Annual General Meeting At the Annual general meeting, the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order  3. Election of persons to scrutinize the minutes

Publicly listed Astralis Group publishes first Annual Report

Friday morning the publicly listed esports company Astralis Group published the company’s first Annual Report.Astralis Group is a publicly listed esports media company who owns and operates three globally leading team brands including all media and commercial rights: Origen (League of Legends - currently no 1 in LEC), Future FC (FIFA) and Astralis (Counter-Strike, currently number 1 on the world rankings). Astralis is listed on Nasdaq First North Growth Market under ASTGRP. Friday morning the publicly listed esports company Astralis Group published the company’s first Annual Report.

Recipharm notes an increased demand for Chloroquine Phosphate

Recipharm, a leading contract development and manufacturing organisation (CDMO), has recently noted an increase in demand for its product Klorokinfosfat RPH Pharma marketed in Sweden by Astimex Pharma. The CDMO has also received questions about the product, which is typically used to treat patients with malaria prophylaxis and rheumatoid arthritis. The reason for the interest in this well-known product is due to chloroquine's antiviral effects, which mean it has been mentioned as a drug that can potentially be used when treating patients with coronavirus COVID-19 associated pneumonia.

CEO Update

Dear shareholders, it has truly been an exciting time since I last communicated to the market Some of the highlights  · SpectrumOne AS, has received a grant from The Research Council of Norway, and the support to apply for an additional of EUR 1.6 million · We have communicated a financial plan for the future of the company including directed issue of shares and loan from a financially strong investor and a warrant plan to be launched in June and November · We have signed agreement regarding acquisition of our highly skilled associated company Cloud Explorers that has

Company Announcement No 4 / 2020: Annual Report 2019

Today the board of Astralis Group A/S approved the annual report for 2019 covering the statutory period 31 July 2019 (date of formation) – 31 December 2019 supplemented with consolidated financial information for the full year 1 January 2019 – 31 December 2019 for the operating group including teams.  Statutory consolidated financial statements - 31 July 2019 – 31 December 2019  Total revenue was DKK 26.8 million, which was DKK 2.8 million higher than expectation. EBITDA was DKK - 5.2 million which was DKK 0.7 million lower than the expectation. The result was DKK -23.9 million.

Arcus ASA: Notice of Annual General Meeting 2020

The Annual General Meeting of Arcus ASA will be held at the company's premises at Destilleriveien 11, Hagan, on 21 April 2020 at 14:00 CET. Attached you will find the notice to the Annual General Meeting, including appendices. The notice is posted electronically or by mail to all shareholders. After the meeting shareholders are welcome to taste a selection of our wines and spirits. For questions, please contact Per Bjørkum, Group Director Communications and IR. Mobile.: +47 92255777, email: per.bjorkum@arcus.no

Annual Report and Corporate Governace Statement of Nurminen Logistics Plc from the year 2019 have been published

The Annual Report and Financial Statement of Nurminen Logistics Plc from the year 2019 has been published at http://www.nurminenlogistics.com . The Corporate Governance Statement 2019 is also available at the site. Nurminen Logistics Plc Tero Vauraste CEOFor more information, please contact: Tero Vauraste, tel. +358 46 87 67 100. DISTRIBUTIONNasdaq HelsinkiMajor Mediawww.nurminenlogistics.com Nurminen Logistics is a listed company established in 1886 that offers logistics services. The company provides high-quality

Safeture offers coronavirus exposure tracking tool to companies for free

Safeture AB today said it is offering its employee safety software to any company looking to track the potential exposure of their workers to the coronavirus now impacting countries around the world. Identifying which employees have been in high-risk areas is critical to effectively containing the spread of the sickness.Starting now, any company, organization, or authority can get free access to the Safeture software platform to have their employees’ travel matched with those hot spot locations most impacted by the virus. Safeture can import trip data from travel agencies plus get real-time

Agreement reached between SpectraCure and one more hospital - Memorial Sloan Kettering Cancer Center i n New York

SpectraCure AB (publ) and Memorial Sloan Kettering Cancer Center in New York, USA, have today signed an agreement, which means that the hospital will be the fourth hospital in SpectraCure's clinical program. A formal meeting ("Site Initiation Visit") for the start-up and review of routines and equipment will be arranged between the company and the hospital next week. In connection with the signing of the agreement, SpectraCure makes a notification to the Food and Drug Administration (FDA) about adding a hospital and we estimate that Memorial Sloan Kettering Cancer Center may begin the study

NEUR SAISON-WHISKY VON MACKMYRA – INSPIRIERT DURCH JAPANISCHE TEEKULTUR

Anfang März stellt Mackmyra zu Ehren der Master-Blenderin Angela D’Orazio den neuen Saison-Whisky „Grönt Te“ vor. Mackmyra „Grönt Te“ ist ein schwedischer Single Malt Whisky, der seine Reifung zum Teil in Fässern erhielt, die Angela D’Orazio zuvor mit einer Mischung aus ausgesuchten japanischen Grünteeblättern gesättigt hat. Mackmyra „Grönt Te“ erhalten Sie ab dem 5. März 2020.2019 war für Mackmyra ein ereignisreiches Jahr. So feierte das Unternehmen sein 20-jähriges Jubiläum als schwedischer Whiskypionier, außerdem wurde die Master-Blenderin Angela D’Orazio in die prestigeträchtige Hall of

There are no items matching the current filter
There are no more items matching the current filter
Back to top